ZEALAND

Anderson Lloyd selects NetDocuments for Cloud Transformation of Document and Email Management

Retrieved on: 
수요일, 2월 21, 2024
Multimedia, Artificial intelligence, DMS, NetDocuments, Microsoft Outlook, Document management system, History, PMS, Lawyer, Cryptocurrency

SYDNEY, Feb. 21, 2024 /PRNewswire-PRWeb/ -- NetDocuments, the #1 trusted cloud platform for law firms, corporate legal teams and business organisations, today announced that Anderson Lloyd has selected NetDocuments as its new Document Management System (DMS). Anderson Lloyd is a leading New Zealand law firm with a history of supporting the industries that make the country successful. Today, the firm has more than 170 partners and staff across its offices in Auckland, Christchurch, Dunedin and Queenstown. It is the latest in a growing number of top tier New Zealand law firms, including two of the 'big three', to adopt NetDocuments.

Key Points: 
  • New Zealand law firm adopts secure, future-proof platform
    SYDNEY, Feb. 21, 2024 /PRNewswire-PRWeb/ -- NetDocuments, the #1 trusted cloud platform for law firms, corporate legal teams and business organisations, today announced that Anderson Lloyd has selected NetDocuments as its new Document Management System (DMS).
  • Anderson Lloyd is a leading New Zealand law firm with a history of supporting the industries that make the country successful.
  • NetDocuments will provide Anderson Lloyd with a future-proof platform, enabling it to embrace technology innovation in a responsible way.
  • Richard Greenaway, CEO of Anderson Lloyd, commented: "NetDocuments' security features and future-proof product roadmap really stood out.

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Retrieved on: 
목요일, 3월 9, 2023
Exercise, DKK, Nasdaq Copenhagen, Property management, Security (finance), Zealand Pharma

The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs.

Key Points: 
  • The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs.
  • Employee warrant programs are part of Zealand Pharma’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a prespecified price, the exercise price, in specific predefined time periods before expiration.
  • Following registration of the new shares, the share capital of Zealand Pharma will be nominal DKK 51,968,463 divided into 51,968,463 shares with a nominal value of DKK 1 each.
  • The amendments to Zealand Pharma’s Articles of Association entailed by the share capital increase have been set out below.

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Retrieved on: 
목요일, 9월 8, 2022
AstraZeneca, NASDAQ, DK, Exercise, Nasdaq Copenhagen, DKK, Nasdaq, Company, Boehringer Ingelheim, Patient, Fine chemical, Security (finance), Zealand Pharma, Association

The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs.

Key Points: 
  • The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs.
  • Employee warrant programs are part of Zealand Pharmas incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a pre specified price, the exercise price, in specific predefined time periods before expiration.
  • The amendments to Zealand Pharmas Articles of Association entailed by the share capital increase have been set out below.
  • Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines.

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Retrieved on: 
목요일, 8월 18, 2022
Exercise, DK, Patient, Boehringer Ingelheim, Company, Nasdaq Copenhagen, NASDAQ, DKK, Nasdaq, AstraZeneca, Fine chemical, Security (finance), Association, Zealand Pharma

The increase is a consequence of the exercise of warrants granted under one of Zealand Pharma's employee warrant programs.

Key Points: 
  • The increase is a consequence of the exercise of warrants granted under one of Zealand Pharma's employee warrant programs.
  • Employee warrant programs are part of Zealand Pharmas incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a pre specified price, the exercise price, in specific predefined time periods before expiration.
  • The amendments to Zealand Pharmas Articles of Association entailed by the share capital increase have been set out below.
  • Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines.

The Spotlight Is On New Production Show Debuting Onboard Discovery Princess(SM)

Retrieved on: 
화요일, 2월 8, 2022
Midnight, Mexican Riviera, Carnival Corporation & plc, Bonded warehouse, Majestic Princess, Sky Princess, Southpacific, Tell Me, CCL, Pacific Overtures, Bodyguard, Safety, Princess Cruises, Footloose, Premios Max, The Wedding Singer, Love Me Tender, Donmar Warehouse, The Sanctuary, BBC, Ant, Lighting, Port, Take, Dance, Music, View, Music of Asia, Pacific Ocean, Princess, San Francisco Ballet, Top Hat, Health, Season, Discovery Princess, Environment, Musical, Pink, Port of Los Angeles, Television, Usher, The Last Tango, COVID-19, Hubbard Street Dance Chicago, Riviera, Rock, Multimedia, Compliance, World Cruising Club, Tourism, Nightclub, Entertainment, Film

SANTA CLARITA, Calif., Feb. 8, 2022 /PRNewswire/ --Princess Cruises guests will be delighted by the newest, original production show Spotlight Bar debuting in April onboard the cruise line's newest ship, Discovery Princess.

Key Points: 
  • SANTA CLARITA, Calif., Feb. 8, 2022 /PRNewswire/ --Princess Cruises guests will be delighted by the newest, original production show Spotlight Bar debuting in April onboard the cruise line's newest ship, Discovery Princess.
  • "We hope Discovery Princess guests will get lost in the familiar music and theme of camaraderie to truly connect with our talented Princess entertainers."
  • Spotlight Barwill debut in the Princess Theater onboard Discovery Princess departing Los Angeles on April 17, 2022, sailing to the Mexican Riviera.
  • The show will be performed live by the enthusiastic Princess singers, dancers and musicians on every Discovery Princess voyage.

Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and Products

Retrieved on: 
화요일, 2월 8, 2022
Drug Quality and Security Act, GLOBE, Forward-looking statement, Securities Act of 1933, Time, Q-Symbio, Company, Oil, International, GMP, Achievement, Annual report, Hospital, Patient, Pharmacy, Securities Exchange Act of 1934, SEC, EDGAR, Life, TSX, Health, Goal, Physician, Nasdaq, Communication, Pharmaceutical industry, Tilray

By unifying the global medical divisions of Tilray and Aphria under a cohesive strategy and mission, Tilray Medical emerges as the premier global supplier of a portfolio of high-quality, effective medical cannabis brands and products for patients in need around the world."

Key Points: 
  • By unifying the global medical divisions of Tilray and Aphria under a cohesive strategy and mission, Tilray Medical emerges as the premier global supplier of a portfolio of high-quality, effective medical cannabis brands and products for patients in need around the world."
  • Under the Tilray Medical consolidation plan, patients in Canada will have the broadest access to our medical cannabis brands and product choices globally, including Tilray, Aphria, Broken Coast, and Symbios.
  • Subject to local regulatory approvals, Tilray Medical's global portfolio of medical cannabis products includes high-quality and GMP-certified flower, oils, vapes, edibles, and topicals.
  • Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios.

ACCELQ Announces 100% Growth in Annual Revenue as Adoption of its No-Code Test Automation Technology Soars

Retrieved on: 
화요일, 2월 1, 2022
Electronic Design Automation, Data Management, Technology, Other Technology, Software, Networks, Internet, Cloud, Growth, Automation, Publication, DevOps, Database, Goal, Technology, Adoption, Research, VP, Forrester, API, Machine learning, Medical device, Gartner

ACCELQ , the leading AI-powered continuous test automation platform, recently concluded a year of record results and is poised for rapid growth.

Key Points: 
  • ACCELQ , the leading AI-powered continuous test automation platform, recently concluded a year of record results and is poised for rapid growth.
  • Additionally, Forrester named ACCELQ as a leader in The Forrester WaveTM: Continuous Functional Test Automation Suites, Q2 2020.
  • ACCELQ allows businesses to achieve 3x productivity and over 70% savings with its industry-first autonomics-based automation platform.
  • ACCELQ was named as a leader in the Forrester WaveTM: Continuous Test Automation Suites, Q2 2020 report.

KYNDRYL UPDATES REPORTING SEGMENTS

Retrieved on: 
월요일, 1월 31, 2022
Growth, Private Securities Litigation Reform Act, Register, KD, Contract, Failure, IBM, Ecosystem, SEC, Telephone, Technology, Securities Act of 1933, Associated Press v. Meltwater U.S. Holdings, Inc., United, Regulation, U.S. Securities and Exchange Commission, Regulation S-X, Company, Health, Geography, EBITDA, Security (finance), IBM Global Services, COVID19, NYSE, Risk, GAAP, Marketing, Public relations, Table

(NYSE:KD), the world's largest IT infrastructure services provider, today announced new geographic reporting segments and segment metrics to better reflect how the Company analyzes business performance.

Key Points: 
  • (NYSE:KD), the world's largest IT infrastructure services provider, today announced new geographic reporting segments and segment metrics to better reflect how the Company analyzes business performance.
  • "Kyndryl now has the freedom of action to develop a broader ecosystem of technology partners and service offerings relevant to our customers, so we're updating our reporting segments to better match how we operate and make decisions across our newly independent company," said Chief Financial Officer David Wyshner.
  • "These reporting changes will help investors and analysts track our progress toward revenue growth and increased profitability and help people see how we're running Kyndryl for long-term success."
  • The Company's reporting of fourth quarter and full-year 2021 results will reflect these segments.

Discovery Princess Officially Delivered to Princess Cruises

Retrieved on: 
월요일, 1월 31, 2022
Safety, View, Royal-class cruise ship, CCL, Port, Riviera, Sky Princess, World Cruising Club, Carnival Corporation & plc, Discovery Princess, Southpacific, COVID-19, Pacific Ocean, Friends, Princess Cruises, Health, Compliance, Medal, Ownership, Today, The Sanctuary, Multimedia, Beauty, Princess, Majestic Princess, Tourism, Fincantieri

Discovery Princess expands the Princess Cruises fleet to 15 MedallionClass vessels and features an evolution of the design platform used for the cruise line's previous Royal-Class ships.

Key Points: 
  • Discovery Princess expands the Princess Cruises fleet to 15 MedallionClass vessels and features an evolution of the design platform used for the cruise line's previous Royal-Class ships.
  • The Discovery Princess handover was attended by John Padgett, President of Princess Cruises, Captain Gennaro Arma, and Luigi Matarazzo, General Manager Merchant Ships Division of Fincantieri.
  • "Today marks a significant milestone for Princess Cruises as we officially take ownership of the spectacular Discovery Princess," said John Padgett, Princess Cruises president.
  • The 3,660-guest Discovery Princess is the sixth and final Royal-Class newbuild and shares all of the spectacular style and luxury of her sister ships Enchanted Princess, Sky Princess, Majestic Princess, Regal Princessand Royal Princess.

Nextech AR Launches Shopify App For 3D Model Making

Retrieved on: 
목요일, 1월 27, 2022
Mobile, Wireless, Technology, Office Products, Home Goods, Internet, Fashion, Data Management, Retail, Consumer Electronics, Online Retail, WooCommerce, VCM, Solution, LinkedIn, YouTube, CMS, Forward-looking statement, Adoption, Arit Okpo, Software as a service, Learning, NEO, Sears, Technology, FSE, 3D, Legislation, Nex Entertainment, The Office Group, Twitter, Company, Instagram, Magento, NTAR, Kmart Australia, International Trade Office Group, AR, Phrase, AI, N29, CSE, Online shopping, Facebook, Shopify, Amazon, Metaverse, BigCommerce

With this App going live, its ARitize 3D SaaS offering for ecommerce extends the Company's 3D model creation capabilities to Shopify merchants.

Key Points: 
  • With this App going live, its ARitize 3D SaaS offering for ecommerce extends the Company's 3D model creation capabilities to Shopify merchants.
  • This App provides Shopify merchants with a frictionless and seamless one click integration for 3D model making as more ecommerce businesses are looking for 3D models at an affordable price and at scale.
  • Nextechs app makes the adoption of 3D/AR super easy, simple and cheap for Shopify merchants as they can subscribe for and manage the app themselves from their merchant Shopify admin.
  • This app reflects the latest and best features of our AR ecommerce platform and will allow Nextech to meet the huge demand for 3D and AR solutions on the largest ecommerce platform in North America.